Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer

NCT01098357 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot Ulcers

Interventions

DRUG: Biochaperone PDGF-BB Low dose
DRUG: Biochaperone PDGF-BB High dose
DRUG: Regranex
DRUG: Biochaperone PDGF-BB Very Low Dose

Sponsor

Virchow Group

Collaborators

[object Object]